Description
Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza3-Respiratory Syncytial Virus Vaccine Modified Live Virus. Express® 5 contains neomycin as a preservative. Features
Contains IBR-BVD Types 1 2 PI3-BRSV modified live virus.
IBR fraction stimulates serological and cell mediated immune (CMI) response. Sub-Q administration; 2 mL dose. Benefits
Provides a proven efficacious immune response in healthy susceptible cattle.
Provides extremely high serological titers and broad effective coverage for BVD.
Includes BVD Type 2 protection.
Provides cattle with the capability to launch a serological and CMI response against an IBR challenge.
Meets BQA guidelines.
No milk withholding.
Advantages
Express 5 administration allows cattle to launch a serological and CMI response against an IBR challenge and provides BVD protection with extremely high serological titers. Dosage Administration
Using aseptic technique inject a 2 mL dose Sub-Q in front of the shoulder and midway of the neck away from the suprascapular lymph node. If initial vaccination repeat the BRSV fraction in 14 to 28 days. A 2 mL booster dose is recommended annually. Calves vaccinated under 6 months of age should be revaccinated at weaning or at 6 months of age. Precautions
Store out of direct sunlight at 35° - 45° F (2° - 7° C). Avoid freezing. Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days of slaughter. Stressed cattle should not be vaccinated. Do not use in pregnant cows or in calves nursing pregnant cows. Burn containers and all unused contents. Injection site swelling may occur. Anaphylactoid reactions may occur. Antidote: Epinephrine. Uses
Express 5 is recommended for vaccination of healthy susceptible cattle as an aid in the reduction of diseases caused by IBR BVD Types 1 2 PI3 BRSV. Warning
Animal inoculation only. Accidental injection to humans can cause serious local reactions. Contact a physician immediately if accidental injection occurs.
MLV BVD vaccine is contraindicated in persistently infected cattle and use should be limited only to healthy immunocompetent unstressed non-pregnant cattle. Highlights
- Protects against IBR-BVD Types 1 2 PI3-BRSV.
- Provides broad coverage and extremely high serological titers for BVD.
- IBR fraction stimulates a CMI response.
- Use in cattle of all ages.
- Sub-Q administration; 2 mL dose.
| 
